Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)

Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo Young Kim; Gabriella Rodolico; Stefano Pepe; Giampaolo Tortora; Liberato Berrino; Ho Young Lee; John V. Heymach; Fortunato Ciardiello

doi:10.1002/jcp.21540

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)

Tina Cascone, Maria Pia Morelli, Floriana Morgillo, Woo Young Kim, Gabriella Rodolico, Stefano Pepe, Giampaolo Tortora, Liberato Berrino, Ho Young Lee, John V. Heymach, Fortunato Ciardiello

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	290
Number of pages	1
Journal	Journal of Cellular Physiology
Volume	217
Issue number	1
DOIs	https://doi.org/10.1002/jcp.21540
State	Published - Oct 2008

ASJC Scopus subject areas

Physiology
Clinical Biochemistry
Cell Biology

Access to Document

10.1002/jcp.21540

Cite this

Cascone, T., Morelli, M. P., Morgillo, F., Kim, W. Y., Rodolico, G., Pepe, S., Tortora, G., Berrino, L., Lee, H. Y., Heymach, J. V., & Ciardiello, F. (2008). Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444). Journal of Cellular Physiology, 217(1), 290. https://doi.org/10.1002/jcp.21540

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444). / Cascone, Tina ; Morelli, Maria Pia; Morgillo, Floriana et al.
In: Journal of Cellular Physiology, Vol. 217, No. 1, 10.2008, p. 290.

Research output: Contribution to journal › Comment/debate › peer-review

Cascone, T , Morelli, MP, Morgillo, F, Kim, WY, Rodolico, G, Pepe, S, Tortora, G, Berrino, L, Lee, HY, Heymach, JV & Ciardiello, F 2008, 'Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)', Journal of Cellular Physiology, vol. 217, no. 1, pp. 290. https://doi.org/10.1002/jcp.21540

Cascone T , Morelli MP, Morgillo F, Kim WY, Rodolico G, Pepe S et al. Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444). Journal of Cellular Physiology. 2008 Oct;217(1):290. doi: 10.1002/jcp.21540

Cascone, Tina ; Morelli, Maria Pia ; Morgillo, Floriana et al. / Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444). In: Journal of Cellular Physiology. 2008 ; Vol. 217, No. 1. pp. 290.

@article{99afc9af01744f42a0418f1d4b70d18e,

title = "Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)",

author = "Tina Cascone and Morelli, {Maria Pia} and Floriana Morgillo and Kim, {Woo Young} and Gabriella Rodolico and Stefano Pepe and Giampaolo Tortora and Liberato Berrino and Lee, {Ho Young} and Heymach, {John V.} and Fortunato Ciardiello",

year = "2008",

month = oct,

doi = "10.1002/jcp.21540",

language = "English (US)",

volume = "217",

pages = "290",

journal = "Journal of Cellular Physiology",

issn = "0021-9541",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)

AU - Cascone, Tina

AU - Morelli, Maria Pia

AU - Morgillo, Floriana

AU - Kim, Woo Young

AU - Rodolico, Gabriella

AU - Pepe, Stefano

AU - Tortora, Giampaolo

AU - Berrino, Liberato

AU - Lee, Ho Young

AU - Heymach, John V.

AU - Ciardiello, Fortunato

PY - 2008/10

Y1 - 2008/10

UR - http://www.scopus.com/inward/record.url?scp=50849138559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50849138559&partnerID=8YFLogxK

U2 - 10.1002/jcp.21540

DO - 10.1002/jcp.21540

M3 - Comment/debate

AN - SCOPUS:50849138559

SN - 0021-9541

VL - 217

SP - 290

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

IS - 1

ER -

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this